# SPEVIGO

NDC: 0597-7705
Generic name: spesolimab-sbzo
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250528

FDA application: BLA761244

## Active ingredients

- SPESOLIMAB: 300 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-7705"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-7705
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41a481ee-3062-45d1-aed5-17e8b105634d